Review Article

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future

Table 2

HIV drug approval/authorization dates.

DrugCanada (Health Canada)US (FDA)Europe (EMEA)

EnfuvirtideJuly 14, 2003March 13, 2003May 5, 2003
TipranavirNovember 21, 2005June 22, 2005October 25, 2005
DarunavirJuly 28, 2006June 23, 2006February 12, 2007
MaravirocSeptember 21, 2007August 6, 2007September 18, 2007
RaltegravirNovember 27, 2007October 12, 2007December 20, 2007
EtravirineAugust 23, 2008January 18, 2008August 28, 2008

US (FDA): United States Food and Drug Administration; EMEA: European Medicines Agency.